Post by
Wino115 on Sep 11, 2023 7:29pm
Any thoughts?
Why has it taken longer than it should to find Patient #1 for the P1 trial?
Which of these reasons is right or wrong?
Criteria making it hard? (To me, not that different than most trials.)
No incentive from Drs as clinic payments may be lowered?
Biopsy lengthen's time - I don't think they're doing the Sort1 staining, but could be wrong?
Patients picking other similar target-drug trials so being crowded out given past results and small size?
Comment by
Lee430 on Sep 12, 2023 8:12am
Considering the guidance Thera gave us for the trial restart date and the statement "quickly enroll patients" I feel an update/explanation is overdue...Maybe addresing this is one of the reasons for their early Q3 date.